Advancing toward a cure
Lupus Therapeutics is the preeminent go-to leader in lupus clinical trials. We partner with biopharmaceutical and biotech companies to identify, develop and deliver potentially life-saving new therapies for lupus through our unique proprietary approach and proven track record of catalyzing, initiating and advancing lupus trials.
Equity and Engagement
Innovating Lupus Clinical Research
Lupus Therapeutics has pioneered programs that aim to address fundamental barriers to clinical research in lupus. We are the only organization with dedicated programs that go beyond one single trial and aim to create better access to clinical research for minorities and underrepresented patient groups. We have introduced novel peer-to-peer support programs and are spearheading initiatives to standardize outcomes measures for the global research community.

The LuCIN difference
The Lupus Clinical Investigators Network or LuCIN, developed and overseen by Lupus Therapeutics, is a lupus clinical trials network comprised of the most reputable academic research medical centers throughout North America. LuCIN leverages the expertise of more than 200 experienced clinician-scientists focused on lupus research and treating more than 25,000 people living with lupus.
